A. AL-Adhreai Et Al. , "Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies," HELIYON , vol.8, no.6, 2022
AL-Adhreai, A. Et Al. 2022. Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies. HELIYON , vol.8, no.6 .
AL-Adhreai, A., ALSaeedy, M., Alrabie, A., Al-Qadsy, I., Dawbaa, S., Alaizeri, Z. M., ... Alhadlaq, H. A.(2022). Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies. HELIYON , vol.8, no.6.
AL-Adhreai, Arwa Et Al. "Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies," HELIYON , vol.8, no.6, 2022
AL-Adhreai, Arwa Et Al. "Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies." HELIYON , vol.8, no.6, 2022
AL-Adhreai, A. Et Al. (2022) . "Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies." HELIYON , vol.8, no.6.
@article{article, author={Arwa AL-Adhreai Et Al. }, title={Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies}, journal={HELIYON}, year=2022}